{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:43:26Z","timestamp":1790765006771,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Behcet\u2019s disease (BD) and Vogt-Koyanagi-Harada disease (VKH) are systemic and recurrent autoimmune diseases associated with abnormal T cell immune response. Complement 3a receptor (C3aR) and complement 5a receptor (C5aR) have been reported to be involved in T cell mediated autoimmune disease. This study aimed to investigate the role of C3aR and C5aR in these two diseases. The C3aR expression in PBMCs was increased in patients with active BD (aBD) and active VKH (aVKH). No statistical difference was found concerning the expression of C5aR in PBMCs between patients with aBD or aVKH and normal controls. After the intraocular inflammation in BD and VKH patients was controlled, the C3aR expression returned back to normal levels. The serum from patients with aBD and aVKH significantly induced C3aR expression by PBMCs. C3a induced IL-6, IL-1\u03b2 and TNF-\u03b1 secretion, while inhibited the production of IL-10 by monocytes. Activation of C3aR in CD4<jats:sup>+<\/jats:sup>T cells could upregulate IL-17 production and inhibit IL-10 production, but had no detectable influence on IFN-\u03b3 production. Our data indicates that increased C3aR expression may lead to over activation of the Th17 cell response and may therefore contribute to the pathogenesis of BD and VKH disease.<\/jats:p>","DOI":"10.1038\/s41598-017-15740-8","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T15:08:20Z","timestamp":1510153700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased Complement 3a Receptor is Associated with Behcet\u2019s disease and Vogt-Koyanagi-Harada disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Chaokui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aize","family":"Kijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"15740_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/bjo.80.9.844","volume":"80","author":"MS Suttorp-Schulten","year":"1996","unstructured":"Suttorp-Schulten, M. S. & Rothova, A. The possible impact of uveitis in blindness: a literature survey. The British journal of ophthalmology \n                           80, 844\u2013848 (1996).","journal-title":"The British journal of ophthalmology"},{"key":"15740_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/02713680500263606","volume":"30","author":"P Yang","year":"2005","unstructured":"Yang, P. et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Current eye research \n                           30, 943\u2013948 (2005).","journal-title":"Current eye research"},{"key":"15740_CR3","doi-asserted-by":"crossref","unstructured":"Davatchi, F. et al. Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol, 1\u20139, (2016).","DOI":"10.1080\/1744666X.2016.1205486"},{"key":"15740_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","volume":"115","author":"P Yang","year":"2008","unstructured":"Yang, P. et al. Clinical features of chinese patients with Behcet\u2019s disease. Ophthalmology \n                           115, 312\u2013318 e314 (2008).","journal-title":"Ophthalmology"},{"key":"15740_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","volume":"114","author":"P Yang","year":"2007","unstructured":"Yang, P. et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology \n                           114, 606\u2013614 (2007).","journal-title":"Ophthalmology"},{"key":"15740_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ajo.2005.04.052","volume":"140","author":"I Bykhovskaya","year":"2005","unstructured":"Bykhovskaya, I., Thorne, J. E., Kempen, J. H., Dunn, J. P. & Jabs, D. A. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol \n                           140, 674\u2013678 (2005).","journal-title":"Am J Ophthalmol"},{"key":"15740_CR7","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","volume":"46","author":"A Klos","year":"2009","unstructured":"Klos, A. et al. The role of the anaphylatoxins in health and disease. Mol Immunol \n                           46, 2753\u20132766 (2009).","journal-title":"Mol Immunol"},{"key":"15740_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2174\/187152809788681038","volume":"8","author":"Q Peng","year":"2009","unstructured":"Peng, Q., Li, K., Sacks, S. H. & Zhou, W. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets \n                           8, 236\u2013246 (2009).","journal-title":"Inflamm Allergy Drug Targets"},{"key":"15740_CR9","doi-asserted-by":"crossref","unstructured":"Strainic, M. G. et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4\u2009+\u2009T cells. Immunity \n                           28, 425-435, doi:S1074-7613(08)00071-X (2008).","DOI":"10.1016\/j.immuni.2008.02.001"},{"key":"15740_CR10","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1182\/blood-2007-06-095018","volume":"11","author":"Q Peng","year":"2008","unstructured":"Peng, Q. et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood1 \n                           11, 2452\u20132461 (2008).","journal-title":"Blood1"},{"key":"15740_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.imbio.2011.07.033","volume":"217","author":"K Li","year":"2012","unstructured":"Li, K. et al. Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology \n                           217, 65\u201373 (2012).","journal-title":"Immunobiology"},{"key":"15740_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.2499","volume":"14","author":"MG Strainic","year":"2013","unstructured":"Strainic, M. G., Shevach, E. M., An, F., Lin, F. & Medof, M. E. Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells. Nat Immunol \n                           14, 162\u2013171 (2013).","journal-title":"Nat Immunol"},{"key":"15740_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1084\/jem.20121525","volume":"210","author":"WH Kwan","year":"2013","unstructured":"Kwan, W. H., van der Touw, W., Paz-Artal, E., Li, M. O. & Heeger, P. S. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med \n                           210, 257\u2013268 (2013).","journal-title":"J Exp Med"},{"key":"15740_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1189\/jlb.3A0415-157R","volume":"99","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis. J Leukoc Biol \n                           99, 447\u2013454 (2016).","journal-title":"J Leukoc Biol"},{"key":"15740_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2249.2009.04070.x","volume":"159","author":"DA Copland","year":"2010","unstructured":"Copland, D. A. et al. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol \n                           159, 303\u2013314 (2010).","journal-title":"Clin Exp Immunol"},{"key":"15740_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jneuroim.2013.08.010","volume":"264","author":"RW Read","year":"2013","unstructured":"Read, R. W., Vogt, S. D. & Barnum, S. R. The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis. J Neuroimmunol \n                           264, 127\u2013129 (2013).","journal-title":"J Neuroimmunol"},{"key":"15740_CR17","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","volume":"122","author":"E Asgari","year":"2013","unstructured":"Asgari, E. et al. C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood \n                           122, 3473\u20133481 (2013).","journal-title":"Blood"},{"key":"15740_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2741\/e777","volume":"8","author":"A Nalbant","year":"2016","unstructured":"Nalbant, A. & Eskier, D. Genes associated with T helper 17 cell differentiation and function. Front Biosci (Elite Ed) \n                           8, 427\u2013435 (2016).","journal-title":"Front Biosci (Elite Ed)"},{"key":"15740_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","volume":"119","author":"W Chi","year":"2007","unstructured":"Chi, W. et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol \n                           119, 1218\u20131224 (2007).","journal-title":"J Allergy Clin Immunol"},{"key":"15740_CR20","doi-asserted-by":"crossref","unstructured":"International Study Group for Behcet\u2019 s disease, Criteria for diagnosis of Behcet\u2019s disease. Lancet \n                           335, 1078\u20131080 (1990).","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"15740_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read, R. W. et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol \n                           131, 647\u2013652 (2001).","journal-title":"Am J Ophthalmol"},{"key":"15740_CR22","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1136\/ard.2009.126383","volume":"69","author":"RA Harry","year":"2010","unstructured":"Harry, R. A., Anderson, A. E., Isaacs, J. D. & Hilkens, C. M. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis \n                           69, 2042\u20132050 (2010).","journal-title":"Ann Rheum Dis"},{"key":"15740_CR23","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.1167\/iovs.13-12159","volume":"54","author":"X Liu","year":"2013","unstructured":"Liu, X., Wang, C., Ye, Z., Kijlstra, A. & Yang, P. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet\u2019s disease. Invest Ophthalmol Vis Sci \n                           54, 6012\u20136017 (2013).","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15740-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15740-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15740-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:37:43Z","timestamp":1671802663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15740-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15740"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15740-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"assertion":[{"value":"15 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15579"}}